We are live on ! Find out more
GRTS

Gritstone bio, Inc. Common Stock

Delisted

GRTS was delisted on the 21st of October, 2024.

91 hedge funds and large institutions have $151M invested in Gritstone bio, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

353% more call options, than puts

Call options by funds: $1.01M | Put options by funds: $222K

118% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 11

76% more capital invested

Capital invested by funds: $86M → $151M (+$65M)

21% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 24

15% more funds holding

Funds holding: 7991 (+12)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
91
Holders Change
+12
Holders Change %
+15.19%
% of All Funds
1.46%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
29
Reduced
24
Closed
11
Calls
$1.01M
Puts
$222K
Net Calls
+$784K
Net Calls Change
+$695K
Name Holding Trade Value Shares
Change
Change in
Stake
LP
101
LMR Partners
United Kingdom
-$39K -15,240 Closed
CS
102
Cannell & Spears
New York
-$30K -11,809 Closed

GRTS Hedge Fund Activity: Q4 2022 in Review

91 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q4 2022, worth a combined $151M — up 76% from $86M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new GRTS positions and 11 closed out — a net gain of 13 holders — while 29 added to existing stakes and 24 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $21.9M. The largest seller was Palo Alto Investors, cutting an estimated $4.75M.

  • 91 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q4 2022, up from 79 in Q3 2022.
  • Funds reported $151M of Gritstone bio, Inc. Common Stock stock for Q4 2022, up 76% quarter-over-quarter.
  • 24 funds opened new Gritstone bio, Inc. Common Stock positions in Q4 2022 and 11 closed out, a net change of +13 holders.
  • The largest Gritstone bio, Inc. Common Stock buyer in Q4 2022 was Point72 Asset Management, an estimated $21.9M added.
  • The largest Gritstone bio, Inc. Common Stock seller in Q4 2022 was Palo Alto Investors, an estimated $4.75M sold.

Based on aggregated 13F filings for Q4 2022.